about
Schizophrenia is associated with an increase in cortical microRNA biogenesisGroup II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortexAf9/Mllt3 interferes with Tbr1 expression through epigenetic modification of histone H3K79 during development of the cerebral cortexMutations in SYNGAP1 in autosomal nonsyndromic mental retardationGABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophreniaPreclinical models of antipsychotic drug action.Glutamatergic autoencephalitides: an emerging fieldGlobal quantitative analysis of phosphorylation underlying phencyclidine signaling and sensorimotor gating in the prefrontal cortex.Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia.NMDA Receptors Mediate Stimulus-Timing-Dependent Plasticity and Neural Synchrony in the Dorsal Cochlear Nucleus.Animal models of serotonergic psychedelics.Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of SchizophreniaHDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors.Neuromapping techniques in drug discovery: pharmacological MRI for the assessment of novel antipsychotics.A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in miceExtensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats.NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: application of laser microdissection technique.Dizocilpine (MK-801) induces distinct changes of N-methyl-D-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortexThe neurobiology of D-amino acid oxidase and its involvement in schizophrenia.Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patientsGenetic and functional analysis of the DLG4 gene encoding the post-synaptic density protein 95 in schizophrenia.A population genetic approach to mapping neurological disorder genes using deep resequencing.Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.Pharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmissionInteraction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm.High novelty-seeking rats are resilient to negative physiological effects of the early life stress.Increased hippocampal CA1 cerebral blood volume in schizophrenia.A case control association study and cognitive function analysis of neuropilin and tolloid-like 1 gene and schizophrenia in the Japanese population.Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophreniaMaternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophreniaEffects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain.From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.Expression pattern of membrane-associated guanylate kinases in interneurons of the visual cortexAltered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia.Translating glutamate: from pathophysiology to treatment.Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.Excessive attractor instability accounts for semantic priming in schizophrenia.
P2860
Q24595592-9A52A38D-CAFB-432C-B5F1-5697F8C2A253Q24612550-F6AD4AF8-74CE-4C44-AF69-02313D0A565BQ24613056-D21A1FEB-63AC-4E26-AE8B-833996EEA7A0Q24629491-93DEA67D-892F-4A04-85F8-4F6CE82ADB19Q24642711-257FEB07-1861-495E-8BCC-7C7514025A79Q26827502-8226FCEF-0217-4BB4-AF9A-F133A06CCA7BQ26992294-A5A7B15E-459E-4B3F-A38D-653766EDDB77Q27319445-60C9B8DF-E5B3-40EB-837B-A92795C32469Q30355619-6D8065E2-73FA-41A2-A310-FDDDC76FC428Q30397669-390D83CE-C3F9-4943-AC48-4674F69AB575Q30444312-21965D87-AD8A-4F19-8DE7-1CFDB89CF4EDQ30453229-0F1713EC-F7E5-43B0-82FD-0AE650299FE7Q30457800-672B66F5-0C94-4699-8241-E51427D164C2Q30491856-9E148EEA-8C83-469E-A43B-4D94DB656AD6Q30564474-902DF525-9214-4941-B79B-927A094E1665Q30651885-0AE38155-12C7-4D8E-AE66-34D0298E33E1Q33328978-F27D366B-2671-4F9A-BB3D-E0A905D3FC01Q33374928-E1F232A6-EC0D-4D50-9E38-1197C87B5732Q33444363-DC04C0A4-A5EE-4562-82D4-459E5B7EF0F6Q33611796-364A37A3-D1B8-40FA-A0D0-3CBF1DCEAADBQ33718794-5901A97E-D4E9-42DB-9B02-ECA731C20AA3Q33769690-121EA47A-6CBC-414A-BDAC-70426157B66DQ33839359-3B86A9E8-8B94-4A2B-97BD-8AEE9AEA4E6DQ33846961-0AACBB9D-BE17-4A06-884C-62546213BBDCQ33942069-CEDEDDAB-3023-4DA0-B31D-F8E4520DA05AQ34021713-187CE997-3492-4F86-8A09-9446F5290AF6Q34077831-042453D0-0CB3-4B1B-9D9E-62C92A26BEE3Q34079242-1A0469D6-0B6A-4781-B2BD-29B4F23461C6Q34113654-19292A04-0635-4499-AAEA-510A359B9DACQ34406087-1034D0F6-6473-4F8D-B008-4ACA1B33D65BQ34566313-BA75BB28-5850-47C8-87DE-73C7A49687CEQ34583614-C34E7E30-840A-4F72-9768-51C25BF1255DQ34628396-831E42D2-1D21-416E-B212-AD5B59002511Q34632695-EF480324-465F-456A-9737-F2EBD4A38C6EQ34659000-B4351041-012A-422C-8013-AAEF9497E724Q35607404-E8B9580B-09D8-4865-B430-185AA2CEC753Q35633518-14C14B64-A827-41FE-880B-60BDD60750FFQ35739457-0014D75B-6B11-485F-98A8-55E7AA667489Q35760215-D9F0CB4C-E7E0-4063-95AC-B81095E8E934Q36109724-EB1B8561-EDE6-49F7-929D-5B2ABD0AC0FB
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
NMDA receptors and schizophrenia.
@ast
NMDA receptors and schizophrenia.
@en
type
label
NMDA receptors and schizophrenia.
@ast
NMDA receptors and schizophrenia.
@en
prefLabel
NMDA receptors and schizophrenia.
@ast
NMDA receptors and schizophrenia.
@en
P2093
P1476
NMDA receptors and schizophrenia
@en
P2093
Ibone Huerta
James H Meador-Woodruff
Monica Beneyto
P356
10.1016/J.COPH.2006.08.013
P577
2006-11-09T00:00:00Z